Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Oct 1.

Published in final edited form as: J Nanomed Nanotechnol. 2016 Aug 12;7(4):393. doi: 10.4172/2157-7439.1000393

Cytotoxicity of G3-Curc () and free Curc () was evaluated by MTT assay against U-251 human malignant glioma (A), MDA-MB-231 breast cancer (B), squamous head and neck cancer (HNSCC) cells, HPV+ (C) and HPV- (D) cells. In vitro studies proved that the cytotoxicity of G3-Curc conjugate was more effective against different types of cancer cells in a dose-dependent manner.

Inline graphic — Cytotoxicity of G3-Curc () and free Curc () was evaluated by MTT assay against U-251 human malignant glioma (A), MDA-MB-231 breast cancer (B), squamous head and neck cancer (HNSCC) cells, HPV+ (C) and HPV- (D) cells. In vitro studies proved that the cytotoxicity of G3-Curc conjugate was more effective against different types of cancer cells in a dose-dependent manner.